InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
2.425
+0.105 (4.53%)
Apr 29, 2025, 10:27 AM EDT - Market open
InspireMD Employees
As of December 31, 2024, InspireMD had 86 total employees, including 85 full-time and 1 part-time employees. The number of employees increased by 20 or 30.30% compared to the previous year.
Employees
86
Change (1Y)
20
Growth (1Y)
30.30%
Revenue / Employee
$81,500
Profits / Employee
-$372,151
Market Cap
74.29M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NSPR News
- 4 days ago - InspireMD to Announce First Quarter 2025 Financial Results - GlobeNewsWire
- 21 days ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - InspireMD, Inc. (NSPR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures - GlobeNewsWire
- 5 months ago - InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR) - GlobeNewsWire